Drug addiction, dysregulation of reward, and allostasis

Neuropsychopharmacology

Volumn 24, Issue 2, 2001, Pages 97-129

  Koob, George F ^a   Le Moal, Michel ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b INSERM   (France)

Author keywords

Allostasis; Drug addiction; Reward dysregulation

Indexed keywords

ALCOHOL; AMPHETAMINE; CENTRAL STIMULANT AGENT; COCAINE; DOPAMINE; DRUG; GLUCOCORTICOID; NICOTINE; OPIATE; TETRAHYDROCANNABINOL;

ADDICTION; COMPULSION; DRUG DEPENDENCE; DRUG WITHDRAWAL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MODEL; NEUROBIOLOGY; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; REWARD; STRESS;

EID: 0035199891     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00195-0     Document Type: Article

References (303)

1. Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion; Pharmacological and behavioral studies
2. Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence
3. Glucocorticoid regulation of preproenkephalin gene expression in the rat forebrain
4. Cocaine- but not food-seeking behavior is reinstated by stress after extinction
5. Transition from moderate to excessive drug intake; Change in hedonic set point
6. Long-lasting increase in the set point for cocaine self-administration after escalation in rats
7. Persistent increase in the motivation to take heroin in rats with a history of drug escalation
8. Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on AVP and CRH mRNA in the rat hypothalamus
9. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders; The striatopallidal, amygdaloid, and corticopetal components of substantia innominata
10. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens
11. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants; Basic findings from the National Comorbidity Survey
12. Breaking the chain of addiction
13. The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent
14. Brain mediation of obsessive-compulsive disorder symptoms; Evidence from functional brain imaging studies in the human and nonhuman primate
15. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder
16. Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning
17. Pimozide blocks establishment but not expression of cocaine-produced environment-specific conditioning
18. Receptor subtype-specific dopaminergic agents and conditioned behavior
19. Antagonism of cocaine self-administration by selective dopamine D1 and D2 antagonists
20. Addiction, dopamine, and the molecular mechanisms of memory
21. Familial transmission of substance dependence; Alcohol, marijuana, cocaine, and habitual smoking - a report from the Collaborative Study on the Genetics of Alcoholism
22. The stress responses; A new perspective
23. Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of D-amphetamine
24. Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role
25. Involvement of the amygdala in stimulus-reward associations; interaction with the ventral striatum
26. Evidence of heterogeneity of genetic effect in Iowa adoption studies
27. An adoption study of genetic and environmental factors in drug abuse
28. The amygdala and emotional memory
29. Mechanisms of emotional arousal and lasting declarative memory
30. Effects of the dopamine D1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat
31. Modulation of cocaine self-administration in the rat through D-3 dopamine receptors
32. Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat
33. Studies on conditions of activity in endocrine organs. XXIX. Sympathin E and sympathin I
34. A quantitative trait locus for alcohol consumption in selectively bred rat lines
35. The role of food deprivation in the maintenance and reinstatement of cocaine-seeking behavior in rats
36. Food deprivation increases oral and intravenous drug intake in rats
37. Autoshaping i.v. cocaine self-administration in rats; Effects of nondrug alternative reinforcers on acquisition
38. A concurrently available nondrug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforced behavior
39. Income alters choice between drug and an alternative nondrug reinforcer in monkeys
40. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats
41. Glucocorticoid regulation of preproenkephalin messenger ribonucleic acid in the rat striatum
42. Strain-specific facilitation of dopamine efflux by delta 9-tetrahydrocannabinol in the nucleus accumbens of rat; An in vivo microdialysis study
43. Limbic activation during cue-induced cocaine craving
44. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis
45. System theory of pain and of opiate analgesia; No tolerance to opiates
46. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area
47. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
48. Genetic animal models in the study of alcoholism
49. Identifying genes for alcohol and drug sensitivity; Recent progress and future directions
50. Alcohol and neurodegeneration
51. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat; An immunohistochemical study
52. Molecular and cellular aspects of nicotine abuse
53. Anxiogenic-like effects limit rewarding effects of cocaine in BALB/cByJ mice
54. Neurobiology of fear responses; The role of the amygdala
55. Brain corticosteroid receptor balance and homeostatic control
56. The effects of food deprivation on the self-administration of psychoactive drugs
57. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. II. Immunohistochemical analysis
58. Increased locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers
59. Experimental approach to individual vulnerability to psychostimulant addiction
60. Glucocorticoids and behavioral effects of psychostimulants; II. Cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels
61. Genetics of alcoholism
62. Drug addiction as dopamine-dependent associative learning disorder
63. Effects of moderate alcohol consumption on the central nervous system
64. Electrophysiological response to neuropeptide Y (NPY) in alcohol-naive preferring and non-preferring rats
65. Serotonergic and dopaminergic involvement in ethanol intake
66. The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat
67. Heroin and cocaine intravenous self-administration in rats; Mediation by separate neural systems
68. Associative processes in addiction and reward; The role of amygdala-ventral striatal subsystems
69. Behaviour in the novel environment predicts responsiveness to d-amphetamine in the rat; A multivariate approach
70. Molecular and cellular adaptations in signal transduction pathways following ethanol exposure
71. Alterations in behavioral and striatal dopamine asymmetries induced by prenatal stress
72. GABAergic modulation of ethanol-induced motor impairment
73. Facilitation of brain stimulation reward by delta-9-tetrahydrocannabinol
74. Ethanol self-infusion into the ventral tegmental area by alcohol-preferring rats
75. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers; Clinical observations
76. Genetic approaches to the analysis of addiction processes
77. Non-contingent electric footshock facilities the acquisition of intravenous cocaine self-administration in rats
78. Nalorphine-induced changes in morphine self-administration in rhesus monkeys
79. Alcohol problems in adoptees raised apart from alcoholic biological parents
80. Activation of memory circuits during cue-elicited cocaine craving
81. The amygdala; Corticotropin-releasing factor, steroids, and stress
82. The basal ganglia and adaptive motor control
83. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain
84. Genetic and environmental contributions to alcohol dependence risk in a national twin sample; Consistency of findings in women and men
85. Statistical methods in genetic research on smoking
86. Gender differences in the genetic contribution to alcoholism risk and to alcohol consumption patterns
87. Corticotropin-releasing factor and neuropeptide Y; Role in emotional integration
88. Piercing together the puzzle of basal forebrain anatomy
89. Specificity in the projection patterns of accumbal core and shell in the rat
90. Both conditioned taste preference and aversion induced by corticotropin-releasing factor
91. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal
92. Stress, arousal, and the pituitary-adrenal system; A psychoendocrine hypothesis
93. Prenatal stress increases the hypothalamo-pituitary-adrenal axis response in young and adult rats
94. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens
95. Cannabinoid receptor localization in brain
96. Central administration of an opiate antagonist decreases oral ethanol self-administration in rats
97. Influence of an alternative reinforcer on human cocaine self-administration
98. The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference
99. N-methyl-D-aspartate receptors and ethanol; Inhibition of calcium flux and cyclic GMP production
100. Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis
101. Individual differences in schedule-induced and conditioned behaviors
102. Sensitization and individual differences to IP amphetamine, cocaine, or caffeine following repeated intracranial amphetamine infusions
103. Individual differences in amphetamine sensitization; Dose-dependent effects
104. Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine
105. Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs
106. Evidence of genetic predisposition to alcoholic cirrhosis and psychosis; Twin concordances for alcoholism and its biological end points by zygosity among male veterans
107. Innate differences of neuropeptide Y (NPY) in hypothalamic nuclei and central nucleus of the amygdala between selectively bred rats with high and low alcohol preference
108. Addiction to cocaine and amphetamine
109. GABA(A) receptor antagonism in the extended amygdala decreases ethanol self-administration in rats
110. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress
111. Impulsivity resulting from frontostriatal dysfunction in drug abuse; Implications for the control of behavior by reward-related stimuli
112. Control of neuronal excitability by corticosteroid hormones
113. Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems
114. Mechanisms of stress; A dynamic overview of hormonal and behavioral homeostasis
115. Further contributions to the study of the evolution of the forebrain
116. Ethanol self-administration in deprived rats; Effects of Ro15-4513 alone, and in combination with flumazenil (Ro15-1788)
117. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice
118. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States; Results from the National Comorbidity Survey
119. Drug therapy in alcoholism
120. Drugs of abuse; Anatomy, pharmacology, and function of reward pathways
121. Animal models of drug addiction
122. Corticotropin-releasing factor, norepinephrine and stress
123. The role of the striatopallidal and extended amygdala systems in drug addiction
124. Cellular and molecular mechanisms of drug dependence
125. Substance dependence as a compulsive behavior
126. Corticotropin releasing factor, stress and behavior
127. The D-1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat
128. Drug abuse; Hedonic homeostatic dysregulation
129. Opponent process and drug dependence; Neurobiological mechanisms
130. Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat
131. Neuroscience of addiction
132. Increased turnover of norepinephrine in the rat cerebral cortex during stress; Role of the locus coeruleus
133. Brain-stimulation reward; A model for drug induced euphoria
134. Psychiatric hospitalization in twins
135. Multiple drug abuse patterns and medical consequences
136. Rationale for maintenance pharmacotherapy of opiate dependence
137. Drug dependence; Stress and dysregulation of brain reward pathways
138. ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans
139. Long-term behavioral and neuroendocrine adaptations to adverse early experience
140. Analog of neuropeptide FF attenuates morphine tolerance
141. Acute tolerance associated with a single opiate administration; Involvement of N-methyl-D-aspartate-dependent pain facilitatory systems
142. Opiate tolerance to daily heroin administration; An apparent phenomenon associated with enhanced pain sensitivity
143. Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time
144. Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF)
145. Effects of withdrawal from nicotine on intracranial self-stimulation
146. Amphetamine and the reward system; Evidence for tolerance and post-drug depression
147. 1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning
148. Mesocorticolimbic dopaminergic neurons; Functional and regulatory roles
149. Mesocorticolimbic dopaminergic network; Functional and regulatory roles
150. Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains
151. Conditioned place preference induced by delta 9-tetrahydrocannabinol; Comparison with cocaine, morphine, and food reward
152. Preclinical research on cocaine self-administration; Environmental determinants and their interaction with pharmacological treatment
153. Science is revolutionizing our view of addiction-and what to do about it
154. Pharmacogenetics of responses to alcohol and genes that influence alcohol drinking
155. Effects of GABAergic agonists and antagonists on various ethanol-induced behavioral changes
156. Ethanol inhibits NMDA-activated ion current in hippocampal neurons
157. Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving
158. Life events-induced decrease of corticosteroid type I receptors is associated with reduced corticosterone feedback and enhanced vulnerability to amphetamine self-administration
159. CRF and urocortin decreased brain stimulation reward in the rat; Reversal by a CRF receptor antagonist
160. D1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat
161. The nicotine antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat
162. Naloxone precipitates nicotine abstinence syndrome in the rat
163. FMRF-NH2-like mammalian octapeptide; Possible role in opiate dependence and abstinence
164. Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF
165. Postcocaine anhedonia; An animal model of cocaine withdrawal
166. Construct validity of a self-stimulation threshold paradigm; Effects of reward and performance manipulations
167. Animal models of drug craving
168. Acamprosate for the treatment of alcohol dependence; A review of double-blind, placebo-controlled trials
169. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence
170. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene
171. Animal models of alcoholism; Neurobiology of high alcohol-drinking behavior in rodents
172. Adrenal steroid actions on brain; Dissecting the fine line between protection and damage
173. Stress, adaptation, and disease; Allostasis and allostatic load
174. Protective and damaging effects of stress mediators
175. Homeostasis
176. Stress and the individual; Mechanisms leading to disease
177. Memory; A century of consolidation
178. The effects of psychosocial services in substance abuse treatment
179. Familial transmission of substance use disorders
180. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis
181. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder
182. Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ
183. Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions
184. Dopaminergic substrates of cocaine-induced place conditioning
185. Stress during pregnancy; Effect on catecholamines in discrete brain regions of offspring as adults
186. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats
187. Psychoactive drug use in evolutionary perspective
188. Under siege; The brain on opiates
189. Molecular and cellular basis of addiction
190. FosB; A molecular mediator of long-term neural and behavioral plasticity
191. A range of research-based pharmacotherapies for addiction
192. Life without neuropeptide Y
193. Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine
194. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine
195. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats
196. Haloperidol and apomorphine effects on ethanol reinforcement in free-feeding rats
197. Anatomical and neurochemical substrates of drug reward determined by the conditioned place preference technique
198. Localization of genes affecting alcohol drinking in mice
199. Factors that predict individual vulnerability to amphetamine self-administration
200. Corticosterone in the range of stress-induced levels possesses reinforcing properties; Implications for sensation-seeking behaviors
201. Behavioral and biological factors associated with individual vulnerability to psychostimulant abuse
202. Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposing to addiction
203. Glucocorticoids as a biological substrate of reward; Physiological and pathophysiological implications
204. Pathophysiological basis of vulnerability to drug abuse; Role of an interaction between stress, glucocorticoids, and dopaminergic neurons
205. Corticosterone levels determine individual vulnerability to amphetamine self-administration
206. Stress, glucocorticoids, and mesencephalic dopaminergic neurons; A pathophysiological chain determining vulnerability to psychostimulant abuse
207. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration
208. Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission
209. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist
210. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared with the 'core' of the rat nucleus accumbens
211. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs
212. The neurobiology of treatment-resistant mood disorders
213. Homeostatic theory of drug tolerance; A general model of physiological adaptation
214. Matching alcoholism treatments to client heterogeneity; Project MATCH posttreatment drinking outcomes
215. GABA antagonist and benzodiazepine partial inverse agonist reduce motivated responding for ethanol
216. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal
217. The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat
218. Benzodiazepine receptors; New vistas
219. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats
220. Altered amygdalar CRF release and increased anxiety-like behavior in Sardinian alcohol preferring rats; A microdialysis and behavioral study
221. Central norepinephrine neurons and behavior
222. Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats
223. Excessive ethanol drinking following a history of dependence; Animal model of allostasis
224. Mu opioid receptor knockout mice do not self-administer alcohol
225. Effects of amperozide, 8-OH-DPAT, and FG 5974 on operant responding for ethanol
226. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine
227. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens
228. The neural basis of drug craving; An incentive-sensitization theory of addiction
229. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal
230. Stress-induced sensitization and glucocorticoids. II. Sensitization of the increase in extracellular dopamine induced by cocaine depends on stress-induced corticosterone secretion
231. Higher and longer stress-induced increase in dopamine concentrations in the nucleus accumbens of animals predisposed to amphetamine self-administration; A microdialysis study
232. From synapse to vesicle; The reuptake and storage of biogenic amine neurotransmitters
233. What is dependence?
234. Oral ethanol reinforcement in the rat; Effect of the partial inverse benzodiazepine agonist RO15-4513
235. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats
236. Sensitization and tolerance in psychostimulant self-administration
237. Abnormal metyrapone tests during cocaine abstinence
238. Morphine-induced increase in D-1 receptor regulated signal transduction in rat striatal neurons and its facilitation by glucocorticoid receptor activation; Possible role in behavioral sensitization
239. Low level of response to alcohol as a predictor of future alcoholism
240. Induction of corticotropin-releasing hormone gene expression by glucocorticoids; Implication for understanding the states of fear and anxiety and allostatic load
241. Allostasis, amygdala, and anticipatory angst
242. Conditioning and opiate withdrawal; The amygdala links neutral stimuli with the agony of overcoming drug addiction
243. Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine; Potentiation with a second morphine treatment
244. Relative sensitivity to naloxone of multiple indices of opiate withdrawal; A quantitative dose-response analysis
245. Obsessive-compulsive disorder
246. A role for volition and attention in the generation of new brain circuitry; Towards a neurobiology of mental force
247. Molecular mechanisms of drug reinforcement and addiction
248. A syndrome produced by diverse nocuous agents
249. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats
250. Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior
251. Conditioning of opioid reinforcement; Neuroanatomical and neurochemical substrates
252. Evidence from rats that morphine tolerance is a learned response
253. Opiate states of memory; Receptor mechanisms
254. An opponent-process theory of motivation. I. Temporal dynamics of affect
255. Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system
256. Allostasis; A new paradigm to explain arousal pathology
257. Biological basis of stress-related mortality
258. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal
259. Chronic flupentixol treatment potentiates the reinforcing properties of systemic heroin administration
260. Factors that determine a propensity for cocaine-seeking behavior during abstinence in rats
261. A selective imidazobenzodiazepine antagonist of ethanol in the rat
262. Dopamine, schizophrenia, mania, and depression; Toward a unified hypothesis of cortico-striato-pallido-thalamic function
263. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys
264. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism
265. Ethanol consumption and resistance are inversely related to neuropeptide Y levels
266. Genetic and environmental contributions to smoking
267. Genetic influences in drug abuse
268. Effects of intracerebroventricular administration of methyl naloxonium chloride on heroin self-administration in the rat
269. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses
270. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites; Substrate for the co-ordination of emotional and cognitive limbs of the stress response
271. Neuropeptide Y; Emerging evidence for a functional role in seizure modulation
272. Addiction, a disease of compulsion and drive; Involvement of the orbitofrontal cortex
273. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers; Implications in addiction
274. Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex
275. Adrenocorticotropin responses following administration of ethanol and ovine corticotropin-releasing hormone in the sons of alcoholics and control subjects
276. Reward and somatic changes during precipitated nicotine withdrawal in rats; Centrally and peripherally mediated effects
277. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence
278. Changes in morphine self-administration in rats induced by prostaglandin E1 and naloxone
279. Neurochemical correlates of cocaine and ethanol self-administration
280. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration
281. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats
282. Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine associated stimulus
283. Synaptic regulation of mesocorticolimbic dopamine neurons
284. Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement
285. Dynamics of drug dependence; Implications of a conditioning theory for research and treatment
286. Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors
287. The effects of a D1 and D2 dopamine antagonist on behavior maintained by cocaine or food
288. Increased lever pressing for amphetamine after pimozide in rats; Implications for a dopamine theory of reward